Plunkett Research Online: Leap Therapeutics

LEAP THERAPEUTICS (LPTX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhib.....


LEAP THERAPEUTICS

Ticker: LPTX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617 714-0360
Fax:
Address: 47 Thorndike Street
Cambridge, MA 02141 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Douglas OnsiCEO/CFO/Director/President/Secretary/Treasurer
Christopher MirabelliChairman of the Board/Director
See More
Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhib.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture